Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients
연구 개요
AMBU-VAX is a prospective, single-center observational study designed to develop and implement an organizational model for delivering recommended vaccinations within a hospital setting. The study targets adult and elderly patients with chronic diseases or immunocompromising conditions who are eligible for vaccination according to national immunization guidelines. Vaccination is actively proposed during outpatient visits, hospital admissions, or at discharge and, when accepted, administered within the hospital or coordinated with local public health vaccination services. The study aims to evaluate the feasibility, uptake, and completion of hospital-based vaccination pathways and to support integration between hospital and territorial prevention services for vulnerable populations.
- 스폰서
- 협력: 화이자
- 적응증
- Chronic Disease, Immunocompromised, HIV Infection, Chronic Kidney Disease, Solid Organ Transplantation, Hematopoietic Stem Cell Transplantation, Cancer, Autoimmune Diseases, Inflammatory Bowel Disease, Asplenia, Frailty
- 중재
- Hospital-Based Vaccination Pathway
- 목표 등록
- 1,500명
- 시작일
- 2026-02-01
- 완료(예정)
- 2027-02-01
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.